Viva Biotech Holdings (VB0 BE) stock market data APIs
€0.1716
-0(-0%)
as of July 18, 2025
Try our APIs with
free plan!
Viva Biotech Holdings Financial Data Overview
Price chart is built with
Anychart
Prev. Close
0.1716
Open
0.1703
High
0.1716
Low
0.1703
52 wk Range
0.055-0.252
Market Cap
1 194 M
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Viva Biotech Holdings data using free add-ons & libraries
Get Viva Biotech Holdings Fundamental Data
Viva Biotech Holdings Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-06-26
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Viva Biotech Holdings News
New
Asian Penny Stocks To Watch In July 2025
The Asian markets have been navigating a complex landscape, with recent U.S. tariffs on countries like Japan and South Korea adding layers of uncertainty. Despite these challenges, opportunities remai...
Viva Biotech Holdings Leads The Charge In Asian Penny Stocks
As global markets navigate a landscape marked by trade negotiations and economic uncertainty, Asia's financial scene remains a focal point for investors seeking opportunities amid evolving conditions....
Viva Biotech's Wholly-Owned Subsidiary Langhua Pharmaceutical Successfully Passes U.S. FDA On-Site Inspection
SHANGHAI, March 28, 2025 /PRNewswire/ -- Zhejiang Langhua Pharmaceutical Co., Ltd. ("Langhua Pharmaceutical"), a wholly-owned subsidiary of Viva Biotech Holdings ("Viva Biotech"), underwent a cGMP (Cu...
Viva Biotech Announces 2024 Annual Results: Significantly Rebounding in Performance with New Stage ahead, AI Leads to a New Era of Novel Drug R&D
Highlights of Annual Results for the Year Ended December 31, 2024 Revenue reached RMB1,986.7 million Gross profit amounted to RMB687.4 million Net profit recorded RMB222.0 million, a significant tu...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
